Work

Abstract A053: CURE AI predicts immunotherapy treatment benefit for SHH-activated/TP53 wild-type but not SHH-activated/TP53 mutant medulloblastomas

Year: 2026

Type: conference-abstract

Source: Cancer Immunology Research

DOI: 10.1158/2326-6074.io2026-a053

Authors: Vitalay Fomin, Ofir Landau, Daniel Khankin, Tal Shor, Tzvi Lederer, Gregory Koushnir, Amit Weiss, Neil Pfister

Institution: University of Alabama at Birmingham

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130408168

Cites:

Cited by:

Related to: